Collegeville, PA, United States of America

Joshi M Ramanjulu

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 10 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshi M Ramanjulu. Retrieved from https://idiyas.com/inventor/joshi-m-ramanjulu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 44.4

 

 

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Inventor Joshi M Ramanjulu

Introduction: Joshi M Ramanjulu is a renowned inventor based in Collegeville, PA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Joshi M Ramanjulu holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Joshi M Ramanjulu has worked for leading research institutions and companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Joshi M Ramanjulu has collaborated with top universities, multinational companies, and fellow inventors, fostering a culture of creativity and knowledge sharing.

Conclusion: Joshi M Ramanjulu's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a pioneering inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…